Renaissance Technologies
PVCT

Renaissance Technologies’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Renaissance Technologies’s Portfolio PVCT Stock Details PVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-803,200
Closed -$80K – 3677
2016
Q3 		$80K Buy
803,200
+750,700
+1,430% +$164K ﹤0.01% 3209
2016
Q2 		$19K Buy
52,500
+32,300
+160% +$12.3K ﹤0.01% 3285
2016
Q1 		$8K Buy
+20,200
New +$8.32K ﹤0.01% 3342
2015
Q4 		– Sell
-16,300
Closed -$9K – 3552
2015
Q3 		$9K Sell
16,300
-49,800
-75% -$25.5K ﹤0.01% 3119
2015
Q2 		$36K Sell
66,100
-12,900
-16% -$10.5K ﹤0.01% 3173
2015
Q1 		$64K Buy
79,000
+59,800
+311% +$49.3K ﹤0.01% 3059
2014
Q4 		$15K Buy
+19,200
New +$17.6K ﹤0.01% 2925

Other funds holding PVCT

CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
HFBOT
Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Renaissance Technologies's PVCT Position: Q4 2016 in Review

Renaissance Technologies sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 803,200 shares — an estimated $80K sold.

Renaissance Technologies first reported a position in PVCT in Q4 2014 and held it in 7 quarters. The position peaked at $80K in Q3 2016. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

  • Renaissance Technologies reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
  • Renaissance Technologies sold 803,200 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $80K.
  • Renaissance Technologies first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q4 2014 and held it in 7 quarters.
  • Renaissance Technologies's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $80K in Q3 2016.
  • 8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.